Atypical antipsychotic: a plain-language definition

Definition

What atypical antipsychotic means

An atypical antipsychotic is a second-generation medication that acts on dopamine and serotonin signaling in the brain. The atypical label distinguishes these drugs from the older first-generation antipsychotics. They were introduced with the aim of treating psychosis while reducing certain movement side effects. Common examples include aripiprazole, quetiapine, risperidone, and lurasidone, each with a somewhat different profile.

In practice these medications do more than their name suggests. They are core treatment for schizophrenia and other psychotic disorders, but they are also widely used in bipolar disorder, both for acute mania and for maintenance, and several are approved as add-on treatment for depression that has not responded to an antidepressant alone. Some, like quetiapine at low doses, are also used for sleep, though that is a secondary use. Dosing and monitoring vary a great deal across the class.

This matters because atypical antipsychotics ask for careful monitoring. They can affect weight, blood sugar, and lipids, so a clinician checks these over time, and a few influence heart rhythm or cause sedation. The trade-off is that for psychosis, mania, and resistant depression, they are often the most effective tool available. Choosing among them is a matching exercise based on the target symptoms and a person's medical profile.

A frequent misconception is that taking an antipsychotic means a person has psychosis. Many people on these drugs have bipolar disorder or depression and have never had a hallucination or delusion. Another misread is assuming all of them are heavily sedating. The class is varied, and some agents are activating rather than calming, which is exactly why selection is individualized.